03.09.2020 16:33:12
|
Stock Alert: Sutro Biopharma Climbs To New 52-week High
(RTTNews) - Shares of Sutro Biopharma Inc. (STRO) are gaining almost 13 percent or $1.43 in Thursday's morning trade at $12.70, after rising to a new 52-week high of $13.91.
Sutro Biopharma's STRO-002 is a folate receptor alpha-targeting antibody-drug conjugate or ADC, currently being investigated in a Phase 1 clinical trial of patients with ovarian and endometrial cancers.
Wednesday, Sutro Biopharma said its ongoing Phase I dose-escalation trial of STRO-002 in ovarian and endometrial cancer demonstrated promising efficacy and safety profile in a heavily pretreated patient population not selected based on receptor expression. The company has scheduled a conference call for September 9 to discuss the updated trial data.
Sutro Biopharma has traded in a range of $6.00 to $13.91 in the past 52 weeks.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sutro Biopharma Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |